New treatment options for alcoholic hepatitis.

The burden of alcoholic liver disease has rapidly grown in the past two decades and is expected to increase further in the coming years. Alcoholic hepatitis, the most florid presentation of alcoholic liver disease, continues to have high morbidity and mortality, with significant financial and healthcare burden with limited treatment options. Steroids remain the current standard of care in severe alcoholic hepatitis in carefully selected patients. No specific treatments are available for those patients who are steroid ineligible, intolerant or unresponsive. Liver transplant has shown good short-term outcome; however, feasibility, ethical and economic concerns remain. Modification of gut microbiota composition and their products, such as lipopolysaccharide, nutritional interventions, immune modulation, increasing steroid sensitivity, genetic polymorphism and epigenetic modification of alcohol induced liver damage, augmenting hepatic regeneration using GCSF are potential therapeutic avenues in steroid non-responsive/ineligible patients. With better understanding of the pathophysiology, using "Omics" platforms, newer options for patients with alcoholic hepatitis are expected soon.

• Publication year

  2016

• Venue

  World Journal of Gastroenterology

• Publication date

  2016-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.3748/wjg.v22.i15.3892PMID 27099434PMCID PMC4823241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis

  2015cited by this paper
• Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis

  2015cited by this paper
• Prednisolone or Pentoxifylline for Alcoholic Hepatitis.

  2015cited by this paper
• Prednisolone or pentoxifylline for alcoholic hepatitis.

  2015cited by this paper
• Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.

  2015cited by this paper
• Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis

  2015cited by this paper
• Early Liver Transplantation for Patients With Acute Alcoholic Hepatitis: Public Views and the Effects on Organ Donation

  2015cited by this paper
• Increased activity of the complement system in the liver of patients with alcoholic hepatitis

  2014cited by this paper
• Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study

  2014cited by this paper
• Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States

  2014cited by this paper
• Alcoholic and non-alcoholic steatohepatitis.

  2014cited by this paper
• Extracorporeal liver support in severe alcoholic hepatitis.

  2014cited by this paper
• CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

  2014cited by this paper
• Alcoholic hepatitis: Potential role of cytokine CCL20 in alcoholic hepatitis

  2014cited by this paper
• Granulocytapheresis for the Treatment of Severe Alcoholic Hepatitis: A Case Series and Literature Review

  2014cited by this paper
• G-CSF therapy for severe alcoholic hepatitis: targeting liver regeneration or neutrophil function?

  2014cited by this paper
• Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot Study

  2014cited by this paper
• Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement.

  2014cited by this paper
• Liver transplantation in alcoholic patients.

  2014cited by this paper
• Serum Metabolomic Profiling in Acute Alcoholic Hepatitis Identifies Multiple Dysregulated Pathways

  2014cited by this paper
• Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?

  2014cited by this paper
• Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines.

  2014cited by this paper
• Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial

  2014cited by this paper
• Combination Therapy in Severe Alcoholic Hepatitis-Doesn't Really Work.

  2013cited by this paper
• Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis

  2013cited by this paper
• Comment to "liver transplantation for patients with alcoholic liver disease: an open question".

  2013cited by this paper
• Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

  2013cited by this paper
• Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis

  2013cited by this paper
• Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

  2013cited by this paper
• Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center.

  2013cited by this paper
• Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course

  2013cited by this paper
• Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial

  2013cited by this paper
• Innate Immunity and Alcoholic Liver Disease

  2012cited by this paper
• Chemokine receptor antagonists.

  2012cited by this paper
• Rifaximin

  2012cited by this paper
• Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis

  2012cited by this paper
• Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

  2012cited by this paper
• Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from the UNOS database

  2012cited by this paper
• Inflammation in alcoholic liver disease.

  2012cited by this paper
• A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis.

  2012cited by this paper
• The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension

  2012cited by this paper
• Molecular targets in the treatment of alcoholic hepatitis.

  2012cited by this paper
• Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.

  2012cited by this paper
• In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis

  2011cited by this paper
• Role of Adaptive Immunity in Alcoholic Liver Disease

  2011cited by this paper
• Early liver transplantation for severe alcoholic hepatitis.

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new targets for therapy

  2011cited by this paper
• Fibrosis in alcoholic and nonalcoholic steatohepatitis.

  2011cited by this paper
• Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

  2011cited by this paper
• Evidence of neutrophil functional defect despite inflammation in stable cirrhosis.

  2011cited by this paper
• The Amount of Alcohol Consumption Negatively Impacts Short-Term Mortality in Mexican Patients With Alcoholic Hepatitis

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• Osteopontin: role in immune regulation and stress responses.

  2011cited by this paper
• Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis

  2010cited by this paper
• Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

  2010cited by this paper
• The Role of Lipid Metabolism in the Pathogenesis of Alcoholic and Nonalcoholic Hepatic Steatosis

  2010cited by this paper
• Alcoholic liver disease and the gut-liver axis.

  2010cited by this paper
• Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series

  2010cited by this paper
• Variant in PNPLA3 is associated with alcoholic liver disease

  2010cited by this paper
• Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data

  2010cited by this paper
• Interleukin‐22 treatment ameliorates alcoholic liver injury in a murine model of chronic‐binge ethanol feeding: Role of signal transducer and activator of transcription 3

  2010cited by this paper
• Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.

  2010cited by this paper
• Alcoholic hepatitis.

  2009cited by this paper
• The interleukin‐17 pathway is involved in human alcoholic liver disease

  2009cited by this paper
• Intestinal decontamination improves liver haemodynamics in patients with alcohol‐related decompensated cirrhosis

  2009cited by this paper
• Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

  2009cited by this paper
• Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

  2008cited by this paper
• Alcohol and lipid metabolism.

  2008cited by this paper
• Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.

  2008cited by this paper
• Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.

  2008cited by this paper
• Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.

  2008cited by this paper
• SnapShot: Cytokines IV.

  2008cited by this paper
• Granulocyte‐colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: A randomized trial

  2008cited by this paper
• Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis.

  2008cited by this paper
• Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.

  2007cited by this paper
• A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

  2007cited by this paper
• Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

  2007cited by this paper
• Role of the proteasome in ethanol-induced liver pathology.

  2007cited by this paper
• Molecular targets.

  2006cited by this paper
• Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis

  2006cited by this paper
• Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial.

  2006cited by this paper
• S-adenosyl-L-methionine for alcoholic liver diseases.

  2006cited by this paper
• Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.

  2006cited by this paper
• G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

  2005cited by this paper
• Liver transplantation in alcoholic patients

  2005cited by this paper
• Intestinal microflora in patients with liver cirrhosis.

  2004cited by this paper
• Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation

  2004cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.

  2004cited by this paper
• A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

  2004cited by this paper
• Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

  2004cited by this paper
• The role of AMP-activated protein kinase in the action of ethanol in the liver.

  2004cited by this paper
• Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

  2004cited by this paper
• Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.

  2003cited by this paper
• Granulocyte-Colony Stimulating Factor Administration Ameliorates Liver Regeneration in Animal Model of Fulminant Hepatic Failure and Encephalopathy

  2003cited by this paper
• Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.

  2003cited by this paper
• Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice.

  2003cited by this paper
• Sensitivity of the 2‐oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion

  2003cited by this paper

• Circulating urobilinogen contributes to Inflammation, Intestinal Permeability and corticosteroid non-response in Severe Alcohol-associated Hepatitis.

  2025cites this paper
• Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis

  2025cites this paper
• New Approaches to Alcohol-Associated Hepatitis.

  2025cites this paper
• Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt

  2024cites this paper
• Alcoholgeassocieerde hepatitis: geschikt voor transplantatie?

  2024cites this paper
• The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease

  2024cites this paper
• Plasma multi-omics outlines association of urobilinogen with corticosteroid non-response, inflammation and leaky gut in Sever Alcoholic Hepatitis

  2023cites this paper
• Comparative Evaluation of the Effect of Hepatoprotectors on Oxidative Homeostasis in the Blood of Patients with Alcoholic Hepatitis: A Randomized Experimental Study

  2023cites this paper
• Glucocorticoid Treatment Strategies in Liver Failure

  2022cites this paper
• Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples

  2022cites this paper
• Veillonella Bacteremia in Alcoholic Hepatitis

  2021cites this paper
• Aronia melanocarpa Prevents Alcohol-Induced Chronic Liver Injury via Regulation of Nrf2 Signaling in C57BL/6 Mice

  2020cites this paper
• The Effects of Gehuajiecheng Decoction on Expression of COX-2, Serum Level of PGE2, TNF-α and IL-6 in Alcoholic Hepatitis

  2020cites this paper
• Fecal microbiota transplantation in alcohol related liver diseases

  2020cites this paper
• Oxidative stress in alcohol-related liver disease

  2020cites this paper
• Predictors of steroid non-response and new approaches in severe alcoholic hepatitis

  2020cites this paper
• Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope

  2020cites this paper
• PTP1B promotes macrophage activation by regulating the NF-κB pathway in alcoholic liver injury.

  2019cites this paper
• The Role of Nutrition in Addiction Recovery

  2019cites this paper
• Severe alcoholic hepatitis: why do we know a lot, but can do so little?

  2018cites this paper
• Advances in the treatment of severe alcoholic hepatitis

  2018cites this paper
• Emerging concepts in alcoholic hepatitis

  2017cites this paper
• Prospective Study on Predictors of Death in Patients with Alcoholic Hepatitis

  2016cites this paper